NATIXIS : A pullback is likely as the price touches the upper bound
Entry price | Target | Stop-loss | Potential |
---|
€3.96 |
€3.66 |
€4.21 |
+7.55% |
---|
Close to the upper bound of the consolidation zone, investors will need to be careful and anticipate selling pressure for stocks in Natixis.
Strengths● The company returns high margins, thereby supporting business profitability.
● The group usually releases upbeat results with huge surprise rates.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● This company will be of major interest to investors in search of a high dividend stock.
● Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 4.25.
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● Below the resistance at 4.25 EUR, the stock shows a negative configuration when looking looking at the weekly chart.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.